Table 1 Maternal and neonatal characteristics. This table shows the main characteristics of mother and children enrolled in the study
From: Specific antibody titer decay in neonates prenatally exposed to Toxoplasma gondii and their mothers
Lebech’s classification of maternal infection | |
111 | 79 (12.4%) |
Others | 541 (85.1%) |
Not known | 16 (2.5%) |
Maternal country of birth | |
Italy | 591 (92.9%) |
European Union | 36 (5.7%) |
Others | 9 (1.4%) |
Maternal age (years) | 30.1 ± 5.3 (15–45) |
Specific symptoms in pregnancy | |
Yes | 63 (9.9%) |
No | 408 (64.2%) |
Not known | 165 (25.9%) |
Prenatal ultrasound scan | |
Normal | 630 (99.1%) |
Pathological | 6 (0.9%) |
Amniocentesis | |
Negative for Toxoplasma DNA | 151 (23.7%) |
Positive for Toxoplasma DNA | 0 |
Not performed | 485 (76.3%) |
Specific prenatal therapy | |
Yes | 505 (79.4%) |
No | 131 (20.6%) |
Time of maternal infection | |
Periconceptional period | 28 (4.4%) |
First trimester | 467 (73.4%) |
Second trimester | 78 (12.3%) |
Third trimester | 41 (6.4%) |
Undetermined | 22 (3.5%) |
Neonatal gender | |
Male | 326 (51%) |
Female | 310 (49%) |
Neonatal gestational age at birth (weeks) | 38.5 ± 1.6 (29–42) |
Neonatal birth weight (grams) | 3127 ± 489.3 (1310–4840) |